Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study

被引：1

作者：

Torres, Tiago ^{[1
,2
]}

Yeung, Jensen ^{[3
,4
,5
,6
]}

Prajapati, Vimal ^{[7
,8
,9
,10
]}

Ribero, Simone ^{[11
]}

Balato, Anna ^{[12
]}

Valerio Marzano, Angelo ^{[13
,14
]}

Cruz, Maria Joao ^{[15
,16
]}

Paiva Lopes, Maria Joao ^{[17
]}

Lazaridou, Elizabeth ^{[18
]}

Carrascosa, Jose-Manuel ^{[19
]}

Alvarenga, Jose Miguel ^{[1
]}

Farinha, Pedro ^{[17
]}

Duarte, Bruno ^{[17
]}

Sood, Siddhartha ^{[20
]}

Rankin, Brian D. ^{[7
]}

Ortoncelli, Michela ^{[11
]}

Caccavale, Stefano ^{[12
]}

Ferrucci, Silvia Mariel ^{[13
]}

Rosa, Gilberto Pires ^{[15
,16
]}

Daponte, Athina Ioanna ^{[18
]}

Silvi, Gianmarco ^{[21
]}

Peris, Ketty ^{[22
,23
]}

Gori, Niccolo ^{[22
,23
]}

Herranz, Pedro ^{[19
]}

Prignano, Francesca ^{[21
]}

Kolios, Antonio ^{[24
,25
]}

Rompoti, Natalia ^{[26
,27
]}

Gkalpakiotis, Spyridon ^{[26
,27
]}

Chiricozzi, Andrea ^{[22
,23
]}

机构：

[1] Ctr Hosp Univ Santo Antonio Porto, Dept Dermatol, Porto, Portugal

[2] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal

[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada

[4] Womens Coll Hosp, Dept Med, Div Dermatol, Toronto, ON, Canada

[5] Sunnybrook Hlth Sci Ctr, Dept Med, Div Dermatol, Toronto, ON, Canada

[6] Prob Med Res, Toronto, ON, Canada

[7] Univ Calgary, Dept Med, Div Dermatol, Calgary, AB, Canada

[8] Dermatol Res Inst, Calgary, AB, Canada

[9] Skin Hlth & Wellness Ctr, Calgary, AB, Canada

[10] Prob Med Res, Calgary, AB, Canada

[11] Univ Turin, Dept Med Sci, Dermatol Clin, Turin, Italy

[12] Univ Campania Luigi Vanvitelli, Unit Dermatol, Naples, Italy

[13] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy

[14] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[15] Unidade Local Saude Sao Joao, Dept Dermatol, Porto, Portugal

[16] Univ Porto, Fac Med, Porto, Portugal

[17] Ctr Hosp Univ Lisboa Cent, Neurol Dept, Lisbon, Portugal

[18] Aristotle Univ Thessaloniki, Dept Dermatol & Venereol, Sch Med, Thessaloniki, Greece

[19] Hosp Univ Germans Trias i Pujol, Barcelona, Spain

[20] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada

[21] Univ Florence, Dept Hlth Sci, Dermatol Sect, Florence, Italy

[22] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslaz, Dermatol, Rome, Italy

[23] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, UOC Dermatol, Rome, Italy

[24] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA

[25] Univ Hosp Bern, Dept Dermatol, Inselspital, Bern, Switzerland

[26] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Fac Med 3, Stare Mesto, Czech Republic

[27] Charles Univ Prague, Fac Med 3, Stare Mesto, Czech Republic

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2025年

关键词：

D O I：

10.1111/jdv.20581

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：6

共 50 条

[41] Effects of Tralokinumab on Clinical and Laboratory Indexes in Atopic Dermatitis: A 24-Week Real-World Study
Hagino, Teppei
Onda, Marina
Saeki, Hidehisa
Fujimoto, Eita
Kanda, Naoko
DERMATITIS, 2024,
[42] Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
Eichenfield, Lawrence F.
Armstrong, April
Guttman-Yassky, Emma
Lio, Peter A.
Chen, Chi-Chang
Hines, Dionne M.
McGuiness, Catherine B.
Ganguli, Sohini
Delevry, Dimittri
Sierka, Debra
Mallya, Usha G.
DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1337 - 1350
[43] Baseline characteristics of the first real-world atopic dermatitis patients on Dupilumab in Germany - interim analysis of the PROLEAD study
Riebel, S.
Augustin, M.
Bley, O.
Schmitt, J.
Sebastian, M.
Zaun, S.
Thaci, D.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 190 - 190
[44] Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
Lawrence F. Eichenfield
April Armstrong
Emma Guttman-Yassky
Peter A. Lio
Chi-Chang Chen
Dionne M. Hines
Catherine B. McGuiness
Sohini Ganguli
Dimittri Delevry
Debra Sierka
Usha G. Mallya
Dermatology and Therapy, 2022, 12 : 1337 - 1350
[45] Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records
Wang, Candice
Kraus, Christina N.
Patel, Krupa G.
Ganesan, Anand K.
Grando, Sergei A.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (02) : 253 - 256
[46] Real-world efficacy of dupilumab re-administration after discontinuation in patients with atopic dermatitis
Matsutani, Masako
Imai, Yasutomo
Miyamoto, Shoko
Inoue, Yukako
Natsuaki, Masaru
Kanazawa, Nobuo
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2024, 7
[47] Real-world effectiveness of persistent tralokinumab use on clinician and patient-reported outcomes in patients with atopic dermatitis in the CorEvitas atopic dermatitis registry
Silverberg, Jonathan
Balu, Sanjeev
Choi, C. Jean
Li, Alvin
Pugach, Oksana
Schneider, Shannon
Simpson, Eric
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[48] Four-year long-term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real-world retrospective study
Kang, Da-Hyun
Kwon, Soon-Hyo
Lew, Bark-Lynn
JOURNAL OF DERMATOLOGY, 2024, 51 (03): : e63 - e65
[49] Tralokinumab as an effective alternative after dupilumab treatment failure in moderate-to- severe atopic dermatitis: A real- world study
George, Shaina E.
Yu, Jiade
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (06) : 1228 - 1230
[50] Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study
Chiricozzi, Andrea
Dal Bello, Giacomo
Gori, Niccolo
Di Nardo, Lucia
Schena, Donatella
Caldarola, Giacomo
Maurelli, Martina
De Simone, Clara
Girolomoni, Giampiero
Peris, Ketty
JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)

← 1 2 3 4 5 →